BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36312851)

  • 1. Mutations in lysine methyltransferase 2C and PEG3 are associated with tumor mutation burden, prognosis, and antitumor immunity in pancreatic adenocarcinoma patients.
    Huang Y; Liu J; Zhu X
    Digit Health; 2022; 8():20552076221133699. PubMed ID: 36312851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
    Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
    Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancer.
    Wang C; Wang Z; Zhao Y; Jia R
    BMC Gastroenterol; 2022 Nov; 22(1):495. PubMed ID: 36451085
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sun Y; Li L; Yao W; Liu X; Yang Y; Ma B; Xue D
    Front Genet; 2021; 12():762160. PubMed ID: 34795697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer.
    Xu Z; Xiang L; Wang R; Xiong Y; Zhou H; Gu H; Wang J; Peng L
    Biomed Res Int; 2021; 2021():8072796. PubMed ID: 34888385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
    Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
    Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer.
    Zhang M; Zhang J
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between histone lysine methyltransferase KMT2C mutation and clinicopathological factors in breast cancer.
    Chen X; Zhang G; Chen B; Wang Y; Guo L; Cao L; Ren C; Wen L; Liao N
    Biomed Pharmacother; 2019 Aug; 116():108997. PubMed ID: 31146111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma.
    Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X
    Front Genet; 2022; 13():848391. PubMed ID: 35601487
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of
    Liu Z; Liu L; Jiao D; Guo C; Wang L; Li Z; Sun Z; Zhao Y; Han X
    Front Genet; 2021; 12():669694. PubMed ID: 34079583
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive Analysis of 5-Methylcytosine (m
    Wang R; Guo Y; Ma P; Song Y; Min J; Zhao T; Hua L; Zhang C; Yang C; Shi J; Zhu L; Gan D; Li S; Li J; Su H
    Front Oncol; 2022; 12():851766. PubMed ID: 35433474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients.
    Zhu G; Pei L; Li Y; Gou X
    Aging (Albany NY); 2020 Feb; 12(3):2132-2141. PubMed ID: 32012118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer type-dependent correlations between TP53 mutations and antitumor immunity.
    Li L; Li M; Wang X
    DNA Repair (Amst); 2020 Apr; 88():102785. PubMed ID: 32007736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycolysis-Related LINC02432/Hsa-miR-98-5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma.
    Tan P; Li M; Liu Z; Li T; Zhao L; Fu W
    Front Pharmacol; 2022; 13():937413. PubMed ID: 35795552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLG Gene Mutation Up-regulates the Abnormal Tumor Immune Response and Promotes the Progression of Prostate Cancer.
    Zhang P; An Z; Sun C; Xu Y; Zhang Z
    Curr Pharm Biotechnol; 2022; 23(14):1658-1670. PubMed ID: 35422210
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
    Front Immunol; 2022; 13():805311. PubMed ID: 35154122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.
    Tian C; Li X; Ge C
    Mol Med; 2021 Jun; 27(1):62. PubMed ID: 34134622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
    Liu B; Dong Z; Lu Y; Ma J; Ma Z; Wang H
    Evid Based Complement Alternat Med; 2022; 2022():3478861. PubMed ID: 36034941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.